- 0 - Medicines manufactured under these conditions What do you want your Patients to receive??

Slides:



Advertisements
Similar presentations
The Health and Safety Risks Counterfeit products Pose to Consumers Christine HUBER 2 December Cancun.
Advertisements

الرابطة الدولية لمكافحة المواد الطبيّة المزورة a WHO initiative to combat counterfeit medical products Dr V. Reggi - World Health Organization.
Copyright of the Health Sciences Authority 2007 ASEAN-China Conference on Combating Counterfeit Medical Products Jakarta, November 2007 Singapore.
Combating Counterfeit Drugs in China Chen Xu Ph.D. Director of Division of Drug Supervision and Inspection Department of Drug Market.
IMPACT Principles and Elements for National Legislation Presented by: Chair, Working Group on Regulatory Implementation, on behalf of Chair, Working Group.
Anti- Piracy Unit (APU) REPUBLIC OF MAURITIUS 1. MAURITIUS 2.
International Medical Products Anti-CounterfeitingTaskforce.
First ASEAN-China Conference on Combating Counterfeit Medical Products Jakarta November 2007 CHOO CHEOK HANG DEPARTMENT OF PHARMACEUTICAL SERVICES.
Select Committee on Economic Development Impact of Cable Theft on Economic Development.
DG Enterprise and Industry Approach on Combating Counterfeit Medicines Council of Europe Conference “Europe against Counterfeit Medicines” Session: Key.
Tom Kubic Executive Director Pharmaceutical Security Institute World Bank Washington 10 March 2005 The Spreading Plague of Counterfeiting.
National Prescription Drug Threat Assessment 2009 National Drug Intelligence Center Drug Enforcement Administration.
Introduction Medication safety is a critical aspect in improving the health of individuals and increasing their quality of life. When used in the proper.
Panel themes of the International Conference “Europe against Counterfeit Medicines” G.N. Gildeeva, Deputy head of the Department of Registration of Medicines.
U.S. Drug Supply Chain Integrity: Protecting Patient Safety CDR Connie Jung, PharmD, PhD LCDR Eleni Anagnostiadis, RPh Office of Drug Security, Integrity,
A Bilcare Singapore Initiative Bilcare © 2007 Privileged Information The Oxford Conference on Innovation & Technology Transfer for Global Health, Oxford,
No /72, Level 2, Sri Balaji Mansion, Dr. Rajkumar Road, Rajajinagar 4th Block, Bangalore , India. Counterfeit Drug Detection | Fake Product.
Combating Counterfeit Medicines Prof Tony Moffat The School of Pharmacy University of London UK.
Counterfeit Medicines and Fight against Counterfeit Medicines.
By Michael Feldman.   Counterfeit medicine is fake medicine. It may be contaminated or contain the wrong or no active ingredient. They could have the.
Brand Protection: In the face of mounting counterfeiting, diversion & other infringements Jim Mentone | Director, Consumer Global Brand Protection.
PAN INDIA OPERATIONS India’s Exclusive Full Spectrum Business Risk Solutions Enterprise SUBSTANTIVE CHALLENGES IN INTELLECTUAL PROPERTY PROTECTION IN INDIA.
PSM India Bejon Misra, Founder Director.
Walsall Healthcare NHS Trust Medicines Management.
Quality of Emergency Contraceptive Pills: Should we worry? Elizabeth Westley, ICEC Coordinator Reproductive Health Supplies Coalition Membership Meeting.
Strengthening the Protection of Intellectual and Industrial Property Rights Deputy Manager Jan Hylleberg The Danish Association of the Pharmaceutical Industry.
MeTa, Solwezi 27 August,2013.  A branded- name drug product is originally discovered and developed by a pharmaceutical company.  Branded-name drugs.
© 2005 Notification and Reporting on Food Incidents: Irish Approach Food & Drugs Authority Bangkok Thailand Dorothy Guina-Dornan.
SCHEDULING OF MEDICINES SAPRAA 13 June Scheduling of Medicines Ephedrine Pseudoephedrine D-nor-pseudoephedrine.
Complete ACTA negotiations and implement in 2010 Expand counterfeiting and piracy database Enhance transparency and monitoring Build respect for IPR’s.
Thais help US stem Internet sales of medicines Do you think this article will be about encouraging or controlling the sale of medicines on the Internet?
Cross-Border Internet Pharmacy: Why are they so dangerous? Louise Binder, Chair Canadian Treatment Action Council.
What You Want to Know About Generic Drugs Generic Drugs: Safe. Effective. FDA-Approved.
©2014 First Conference of Regulatory Authorities in Sudan and Neighbouring Countries Khartoum, 6-8 December 2014 Dr Lembit Rägo Head, Regulation of Medicines.
> In April of 2007, Main Pharmaceutical Inspector created special position for combating counterfeit and illegal medicines > In May,
Tackling the Illicit Trade – JTI’s Approach Sofia, June
John Anderson Chairman The Global Anti-Counterfeiting Group.
Quality Control Approaches for Essential Medicines “Good Intentions – Bad Drugs” The World Bank March 10, 2005.
Saving Lives, Saving Money Lilia Bounab – Healthcare Sales Manager EMEA Ar ł amów hotel, 14-16th June 2015.
Labelling Survey FIP Working Group on Labelling.
Zambia’s Porous Borders & the Influx of Medicines.
Legal considerations of drugs. Objectives Drug standards Pharmacopoeia Food, drug and cosmetic act.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
1 1 © F-D & B, 2002 BALKAN LEGAL FORUM 2002 SOFIA, BULGARIA Dr. Jürgen Brandstätter ADVERTISING ACTIVITIES IN THE LIGHT OF EUROPEAN LAW STANDARDS.
Using Medicines Safely (2:50) Click here to launch video Click here to download print activity.
1 Good Intentions – Bad Drugs Washington, DC Thursday, 10 March 2005 Robert D. Moore, Executive Director; Global Security Group Merck & Co., Inc.
Bad intentions - good policies: Who wins? Case exercise and role play on drug counterfeiting in an LDC context World Bank Case Exercise – all names and.
1 The impact of Off Patents on the Supply Chain Mark James UKMANAGING DIRECTOR.
Development and Implementation of Good Pharmacy Practice Standards in Developing Countries Author: Frokjaer B, International Pharmaceutical Federation.
Barry Ewy, PharmD, JD, MHA CEO Blessings International.
Kyle Purchase and Matt Mastrogiovanni
Quality & Safety of Generic Drugs in the World Market World Bank Conference “Good Intentions – Bad Drugs” March 10, 2005 Washington, D.C. Christine Simmon.
INTRODUCTION AND OBJECTIVES LEGAL ASPECTS AND SOCIO-ECONOMIC IMPLICATIONS REGARDING DRUG COUNTERFEITING CIOBANU CONSTANTIN, CORCIOVĂ ANDREIA Faculty of.
By: Drew Perry. Counterfeit pharmaceutical drugs are fraudulently produced or mislabeled medicines purchased by consumers who believe them to be legitimate.
Issues related to poor IP protection in EMs: Pharmaceutical Example Rob May Commercial Director, Janssen, EMEA Emerging Markets.
Quality Care Standards Authors: Frokjaer B, Grant RL Problem Statement: All practicing pharmacists are obliged to ensure that the service they provide.
Gudbjorg Edda Eggertsdottir President EGA, President Iceland & Strategic Projects, Actavis Rome, 17 June 2013.
Counterfeiting Protection & Reduction MECH 3620 Advanced Manufacturing Process By: Rafael Mendez.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
Overview: The South African IP Policy Review 13 September 2012 MacDonald Netshitenzhe: Chief Director- Policy and Legislation.
Medicines Authority 203,Level 3, Rue D’Argens, Gzira,GZR 1368 Tel: (+356) Fax: (+356) ov.mt Reporting.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024Low Power Wide Area Network.
ACCESS TO QUALITY MEDICINES IN THE REGION-COUNTERFEITING PROBLEMS
Preventative Measures
Trademark Infringement Issues in Central & Eastern Europe
Regulation of Medical Products & Patient Safety- A Narrative Review
a WHO initiative to combat counterfeit medicines
Fight Against Falsified medicines
Dr Manisha Shridhar Regional Advisor WHO-SEARO
Ch 18: Pharmacy.
Presentation transcript:

- 0 - Medicines manufactured under these conditions What do you want your Patients to receive??

- 1 - Counterfeit Medicines A danger to public health Matthew Moodley Legal Director Interim Chair – Pan African Co. SAPRAA 5 September 2008

- 2 - What is meant by “Counterfeit” medicines? “Products marketed with the intent to deceive” “A Global Health Risk” Affects all Countries

- 3 - Not a Generic Issue - What are counterfeit medicines  Branded or generic medicines which contain: ≠the right active ingredient in insufficient quantity ≠no active ingredient ≠another active ingredient to the one on the label ≠the right amount of active ingredient but from an unapproved source (Illegal generics or Diverted medicines)  Substandard medicines also fall within this category when: ≠expiry date extended unofficially ≠incorrect storage - quality problems ≠goods intended for destruction –saved and repackaged

- 4 - The Effect of Counterfeits Not just - or mainly - a commercial issue Can harm or even kill patients Serious health implications There are no “quality” counterfeits

- 5 - Examples  Niger 1995: 2500 people died after receiving fake meningitis vaccine -WHO  Haiti 1998: 89 deaths from paracetamol syrup [diethylene glycol] and in India 1998: 30 infant deaths as well  Cambodia 1999: Fake artusenate actually contained older anti malarial products to which resistance had developed [70 % of artunsenate sold was fake].  SE Asia 2001: 38 % of 104 antimalarials [mostly artusenate products] contained no active ingredient  China 2007

- 6 - Counterfeiting Manufacturing Methods The conditions under which the counterfeit Viagra manufactured… …demonstrates the dangers the counterfeits pose to public health and safety.

- 7 - Counterfeit Ponstan, Colombia

- 8 - Counterfeit Viagra, Egypt Traces of road paint and methamphetamines

- 9 - Lignocaine Counterfeited lignocaine injection discovered at a Central Hospital after reports of unusual hypersensitivity to the “locally” manufactured local anesthetic

Cough Syrup A student at a local polytechnic is being sought by the police for questioning regarding a counterfeit cough preparation seized from backyard manufacturing facilities in a residential area. Cough Syrup

Counterfeit Norvasc,

Counterfeit Lipitor

Channels to Market Pharmacies/ Dispensing Doctors Prescription OTC Generic Counterfeit Sex Shops Recreational use Counterfeit and herbals Street corner vendors Recreational use Generally Counterfeit Influencing factors Cost Stigma of ED Rx Availability No RX Cost

Medicines sold on streets

Medicines sold in market places

The perfect crime?  Organised crime  Huge profits to be made –global earnings $ 35 B p.a.  Penalties in most countries make these crimes worthwhile - Huge rewards for little risk  Counterfeit medicines are manufactured in one country, packaging is printed in another, product is packed in a third  Almost impossible to distinguish between real and fake medicines - can imitate genuine medicines almost perfectly Victims often are not aware of the fact that they have not received the “real” medicine

The Effect of Counterfeits  Erosion of public confidence in - public health care systems, - health care professionals - the pharmaceutical industry - regulatory and law enforcement authorities  Loss of almost 20 % of total medicines market in SA to crime  Impacts on the price of medicines for the legitimate buyers  WHO estimates - 10 % of pharmaceuticals worldwide are counterfeits and - 25 % of medicines in developing countries are fake or substandard

Significant Combined Effort to combat illegal and counterfeit Medicines in SA  Government Agencies Revising legislation Inter-departmental and cross-country working groups Impose severe sanctions on members found guilty of manufacturing, distributing supplying or selling stolen or counterfeit medicines  Need for Increased Education being addressed by all Players Of health care professionals and the public To assist in spotting illegal, stolen, substandard or counterfeit medicines To be on alert for treatment failure  All Pharma Industry Players Introduce special markings and tracking systems Ensure an effective easy reporting system for patients & professionals to report lack of efficacy or unexpected adverse events to maintain an audit trail of medicines bought

What is being done  The Coalition in Africa  Enhancement of internal control measures  Working with DTI, SARS, Law Enforcement unit of MCC, SAPS, Customs, DOJ  Training and awareness campaigns with active industry support Pfizer training session with SARS and DTI (29 August 2007) Regional Anti Counterfeiting conference – (29 October 2007) -SADAC Governmental Agencies  Local task team; streamlined reporting structure; simplified reporting form, direct access –

Success thus far - Lobombo

Success thus far - Lobombo

What can you do ? Be Vigilant Pharmacist are in the forefront

What can you do ? Differences in packaging are subtle but detectable

What can you do

Copy of a legitimate product no active ingredient CounterfeitGenuine

How can you identify a counterfeit?

What do you want your Patients to receive?? Counterfeit Pfizer